The aim of this study was therefore to determine the effects of doxorubicin on apoptosis signalling, autophagy, the MAPK- and PI3K/Akt signalling pathway, cell cycle control and regulators of the EMT process in murine breast cancer tumours. This evidence concerns the gene AKT1 and neoplasm.